FDA completed review of “EIR”

FDA completed their investigation in connection with our own applications VUAB Pharma Inc. for the inspection at our active pharmaceutical ingredient manufacturing facility in Roztoky, Czech Republic which took place on  3-5 11th 2015.

In an accompanying letter, the FDA states that they are classifying our facility as acceptable.